Thomas Smith Biography and Net Worth

Dr. Thomas Smith joined Collegium Pharmaceutical in March of 2022 following the acquisition of BioDelivery Sciences International. Dr. Smith has more than twenty-five years of experience in a variety of leadership roles at various major pharmaceutical companies, including serving as the Chief Medical Officer for BioDelivery Sciences International, Charleston Laboratories, Ameritox and Mallinckrodt Pharmaceuticals. Prior to these, Dr. Smith served in scientific, medical and clinical leadership roles at Abbott Laboratories, Teva Pharmaceuticals and Kendle International. He is a member of several medical and scientific societies, including the American Medical Association and the American Academy of Family Physicians. Dr. Smith earned his M.D. from the Indiana University School of Medicine and a B.S. from Purdue University.

What is Thomas B. Smith's net worth?: The estimated net worth of Thomas B. Smith is at least $1.44 million as of September 13th, 2024. Smith owns 53,816 shares of Collegium Pharmaceutical stock worth more than $1,441,731 as of April 26th. This net worth evaluation does not reflect any other investments that Smith may own. Additionally, Smith receives a salary of $692,910.00 as EVP at Collegium Pharmaceutical. Learn More about Thomas B. Smith's net worth.
How old is Thomas B. Smith?: Smith is currently 63 years old. There are 5 older executives and no younger executives at Collegium Pharmaceutical. Learn More on Thomas B. Smith's age.
What is Thomas B. Smith's salary?: As the EVP of Collegium Pharmaceutical, Inc., Smith earns $692,910.00 per year. There are 4 executives that earn more than Smith. The highest earning executive at Collegium Pharmaceutical is Mr. Joseph J. Ciaffoni, President, CEO & Director, who commands a salary of $1,690,000.00 per year. Learn More on Thomas B. Smith's salary.
How do I contact Thomas B. Smith?: The corporate mailing address for Smith and other Collegium Pharmaceutical executives is 100 Technology Center Drive, Stoughton MA, 02072. Collegium Pharmaceutical can also be reached via phone at (781) 713-3699 and via email at info@collegiumpharma.com. Learn More on Thomas B. Smith's contact information.
Has Thomas B. Smith been buying or selling shares of Collegium Pharmaceutical?: Thomas B. Smith has not been actively trading shares of Collegium Pharmaceutical during the last ninety days. Most recently, Thomas B. Smith sold 9,593 shares of the business's stock in a transaction on Friday, September 13th. The shares were sold at an average price of $36.62, for a transaction totalling $351,295.66. Following the completion of the sale, the executive vice president now directly owns 53,816 shares of the company's stock, valued at $1,970,741.92. Learn More on Thomas B. Smith's trading history.
Who are Collegium Pharmaceutical's active insiders?: Collegium Pharmaceutical's insider roster includes Garen Bohlin (Director), Joseph Ciaffoni (CEO), Joseph Ciaffoni (Pres), Scott Dreyer (EVP), Michael Heffernan (Director), Shirley Kuhlmann (EVP), Thomas Smith (EVP), Colleen Tupper (CFO), and Colleen Tupper (Exec. VP & CFO ). Learn More on Collegium Pharmaceutical's active insiders.
Are insiders buying or selling shares of Collegium Pharmaceutical?: During the last year, insiders at the specialty pharmaceutical company sold shares 12 times. They sold a total of 243,536 shares worth more than $7,872,884.47. The most recent insider tranaction occured on March, 14th when CFO Colleen Tupper sold 977 shares worth more than $29,310.00. Insiders at Collegium Pharmaceutical own 2.5% of the company. Learn More about insider trades at Collegium Pharmaceutical.
Information on this page was last updated on 3/14/2025.

Thomas B. Smith Insider Trading History at Collegium Pharmaceutical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/13/2024	Sell	9,593	$36.62	$351,295.66	53,816

Thomas B. Smith Buying and Selling Activity at Collegium Pharmaceutical

Collegium Pharmaceutical Company Overview

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Today's Range

Now: $26.79

$26.22

$27.09

50 Day Range

MA: $28.40

$24.67

$30.56

2 Week Range

Now: $26.79

$23.23

$42.29

Volume

214,645 shs

Average Volume

443,365 shs

Market Capitalization

$860.82 million

P/E Ratio

11.55

Dividend Yield

N/A

Beta

0.76

Thomas Smith Biography and Net Worth

What is Thomas B. Smith's net worth?

How old is Thomas B. Smith?

What is Thomas B. Smith's salary?

How do I contact Thomas B. Smith?

Has Thomas B. Smith been buying or selling shares of Collegium Pharmaceutical?

Who are Collegium Pharmaceutical's active insiders?

Are insiders buying or selling shares of Collegium Pharmaceutical?